Author

Shingo Yamada

Shino-Test CorporationORCID 0000-0001-9488-668XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Aiko Ishiki· 1 shared Atsushi IwataiD· 1 shared Gen SobueiD· 1 shared Hidenori HommaiD· 1 shared Hikari TanakaiD· 1 shared Hiroyuki AraiiD· 1 shared Hitoshi OkazawaiD· 1 shared Katsutoshi FurukawaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Aiko Ishiki

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Aβ-HMGB1 complex is a pathogenic molecule at the advanced stage of Alzheimer's disease

Hikari Tanaka, Hidenori Homma, Yuki Yoshioka, Kyota Fujita, Shingo Yamada, Katsutoshi Furukawa, Aiko Ishiki, Naoki Atsuta, Masaaki Waragai, Tatsuo Mano, Masahisa Katsuno, Gen Sobue, Hiroyuki Arai, Atsushi Iwata, Hitoshi Okazawa

This study identifies the Aβ-HMGB1 complex as a pathogenic factor in advanced Alzheimer's disease, showing it causes neuronal damage and that targeting HMGB1 improves symptoms in mouse models.

bioRxiv · Jun 12, 2025 · PreprintNeuroscience